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Tuberculosis (TB) in the Caribbean remains a significant
health issue with many countries exceeding the WHO
target of 5 cases / 100,000 populations. As a developing
nation, many of these Caribbean countries face serious
challenges in the diagnosis, treatment, care and manage-
ment of patients with tuberculosis. In light of the cur-
rent problems facing the tuberculosis programs in the
Caribbean, there is a need for studies to be conducted
so as to better understand the epidemiology of this dis-
ease in such a heterogeneous setting. This investigation
describes a first global molecular epidemiological study
on 480 clinical M. tuberculosis isolates from as many
patients, collected in 12 territories of the Caribbean:
Bahamas, Barbados, Belize, Dominica, Guyana, Jamaica,
St. Kitts and Nevis, St. Lucia, St. Vincent and the Grena-
dines, Suriname, Trinidad and Tobago, Turks and Cai-
cos. Analysis of “de-identified” patient data showed that
TB cases more often concerned males (male to female
sex-ratio, 3.1), and persons within age group 25-45
years. The rate of TB/HIV coinfection was unexpectedly
high with rates ranging from 44.4% in Guyana, 42.9% in
Bahamas, 30.6% in Trinidad and Tobago, 21.4% in Suri-
name, 14.3% in Barbados and 13.5% in Jamaica. The
highest rate of drug-resistant TB was observed in
Guyana (27.8%, among which 76% were multidrug-resis-
tant). Spoligotyping generated a total of 104 distinct pat-
terns for the 480 isolates studied; 49 patterns containing
425 isolates (88.5%) corresponded to clustered strains
(2-93 isolates per cluster), while the remaining 55 pat-
terns corresponded to unclustered strains (11.5%). A
comparison of the spoligotypes with the SITVIT2 global
database showed that the isolates belonged to the
following predominant genotypic lineages: the ill-defined
T lineage (31.0%), East-African Indian (EAI, 19.0%),
Latin American and Mediterranean (LAM, 10.4%), the X
clade (8.3%), Haarlem (5.8%), and Beijing (3.5%). The
diversity of strains circulating in the Caribbean essen-
tially represented their colonial past (clades of European
descent such as Haarlem, and X clades) as well as popu-
lation movements (EAI, Beijing). Lineages characteristic
of the Indian subcontinent (East- African-Indian, Cen-
tral-Asian) were seen in Trinidad and Tobago, Guyana,
and Suriname where there is a large population of East
Indians brought during the indentureship period, after
slavery was abolished. Lastly, a peculiar local evolution
of M. tuberculosis strains in Trinidad and Tobago was
evidenced with the exclusive local emergence of a speci-
fic TB clone (named SIT566, belonging most probably
to the X clade), which resulted in 56% of all TB cases.
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